First National Trust CO Amgen Inc Transaction History

First National Trust CO

  • $2.44 Billion
  • Q1 2024

A detailed history of First National Trust CO transactions in Amgen Inc stock. As of the latest transaction made, First National Trust CO holds 58,105 shares of AMGN stock, worth $18.1 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
58,105
Previous 45,328 28.19%
Holding current value
$18.1 Million
Previous $13.1 Million 26.54%
% of portfolio
0.68%
Previous 0.58%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024
BUY
$268.87 - $324.56 $3.44 Million - $4.15 Million
12,777 Added 28.19%
58,105 $16.5 Million
Q4 2023

Feb 06, 2024
SELL
$255.7 - $288.46 $336,756 - $379,901
-1,317 Reduced 2.82%
45,328 $13.1 Million
Q3 2023

Nov 06, 2023
SELL
$218.65 - $271.46 $172,514 - $214,181
-789 Reduced 1.66%
46,645 $12.5 Million
Q2 2023

Aug 01, 2023
SELL
$214.27 - $253.37 $158,345 - $187,240
-739 Reduced 1.53%
47,434 $10.5 Million
Q1 2023

Apr 26, 2023
BUY
$225.79 - $275.2 $418,840 - $510,496
1,855 Added 4.0%
48,173 $11.6 Million
Q4 2022

Feb 02, 2023
SELL
$229.03 - $291.01 $25,880 - $32,884
-113 Reduced 0.24%
46,318 $12.2 Million
Q3 2022

Nov 02, 2022
BUY
$224.46 - $253.15 $388,091 - $437,696
1,729 Added 3.87%
46,431 $10.5 Million
Q2 2022

Aug 03, 2022
BUY
$230.71 - $256.74 $2.48 Million - $2.76 Million
10,741 Added 31.63%
44,702 $10.9 Million
Q1 2022

May 03, 2022
BUY
$219.27 - $242.57 $42,976 - $47,543
196 Added 0.58%
33,961 $8.21 Million
Q4 2021

Feb 03, 2022
BUY
$198.88 - $227.6 $1.55 Million - $1.77 Million
7,786 Added 29.97%
33,765 $7.6 Million
Q3 2021

Nov 05, 2021
SELL
$212.27 - $248.7 $65,166 - $76,350
-307 Reduced 1.17%
25,979 $5.52 Million
Q2 2021

Aug 06, 2021
SELL
$233.58 - $259.14 $1.18 Million - $1.31 Million
-5,072 Reduced 16.17%
26,286 $6.41 Million
Q1 2021

May 06, 2021
SELL
$221.91 - $258.6 $3.71 Million - $4.32 Million
-16,712 Reduced 34.77%
31,358 $7.8 Million
Q4 2020

Feb 10, 2021
BUY
$216.38 - $257.67 $241,480 - $287,559
1,116 Added 2.38%
48,070 $11.1 Million
Q3 2020

Nov 04, 2020
BUY
$234.65 - $260.95 $334,845 - $372,375
1,427 Added 3.13%
46,954 $11.9 Million
Q2 2020

Aug 06, 2020
BUY
$197.81 - $242.74 $144,796 - $177,685
732 Added 1.63%
45,527 $10.7 Million
Q1 2020

Apr 29, 2020
SELL
$182.24 - $241.7 $808,598 - $1.07 Million
-4,437 Reduced 9.01%
44,795 $9.08 Million
Q4 2019

Feb 04, 2020
BUY
$189.21 - $243.2 $138,123 - $177,536
730 Added 1.51%
49,232 $11.9 Million
Q3 2019

Nov 01, 2019
BUY
$174.11 - $208.62 $156,350 - $187,340
898 Added 1.89%
48,502 $9.39 Million
Q2 2019

Jul 22, 2019
SELL
$166.7 - $195.41 $216,209 - $253,446
-1,297 Reduced 2.65%
47,604 $8.77 Million
Q1 2019

Apr 25, 2019
BUY
$180.87 - $203.88 $63,485 - $71,561
351 Added 0.72%
48,901 $9.29 Million
Q4 2018

Jan 28, 2019
BUY
$178.4 - $208.25 $1.11 Million - $1.29 Million
6,196 Added 14.63%
48,550 $9.45 Million
Q3 2018

Oct 31, 2018
BUY
$185.29 - $208.89 $102,280 - $115,307
552 Added 1.32%
42,354 $0
Q2 2018

Jul 30, 2018
BUY
$166.05 - $186.51 $272,820 - $306,435
1,643 Added 4.09%
41,802 $7.72 Million
Q1 2018

Apr 30, 2018
BUY
$169.43 - $198.0 $501,682 - $586,278
2,961 Added 7.96%
40,159 $6.85 Million
Q4 2017

Jan 17, 2018
BUY
$168.79 - $188.59 $493,710 - $551,625
2,925 Added 8.53%
37,198 $6.47 Million
Q3 2017

Nov 06, 2017
BUY
$167.29 - $191.0 $208,108 - $237,604
1,244 Added 3.77%
34,273 $6.39 Million
Q2 2017

Aug 07, 2017
BUY
N/A
33,029
33,029 $5.69 Million

Others Institutions Holding AMGN

# of Institutions
2,933
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First National Trust CO Portfolio

Follow First National Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email